Sorrento Therapeutics Inc (SRNE)

[dia76ca]

The open secret is that Sorrento will earn large revenues in 2022! (roughly in this order?)
1. COVISTIX revenue stream is just beginning. Watch sales increase as manufacturing ramps up. Mexico, Brazil, South and Central America and Europe are an enormous market!
2. ABIVERTINIB $61 Billion global market partnership(s). 8 months from first mention. Multi-Billion upfront, milestone and royalties!
3. SEMDEXA advances. Sciatica market in US alone is $3-5+ Billion. Label expansion to knee, shoulder, wrist, ankles and joints could add 50-200%
4. COVI-MSC for ARDS and LongHaul Covid. Look for Brazil, Mexico and Europe approvals first. Multi-blockbuster.
5. COVISHIELD 2 minute injections and nasal drops. Mexico, Brazil, Europe and UK lead the way. Another Multi-blockbuster.
6. Oral pan-corona anti-viral Mpro could be the biggest surprise of all. Appears to be safer and more powerful than Pfizer or Merck drugs!

And if the Corporate controlled FDA starts to put patients first there will even be US approvals!